Cargando…

Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study

OBJECTIVES: To evaluate treatments and prognostic factors for the myxoid liposarcoma in extremities. METHODS: We retrospectively reviewed 34 patients histologically diagnosed with myxoid liposarcoma arising in the extremities, treated in our hospital from 2010 to 2017. We recorded tumor locations, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Kai, Yu, Xiu‐chun, Xu, Ming, Yang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904597/
https://www.ncbi.nlm.nih.gov/pubmed/31721459
http://dx.doi.org/10.1111/os.12566
_version_ 1783478026896408576
author Zheng, Kai
Yu, Xiu‐chun
Xu, Ming
Yang, Yang
author_facet Zheng, Kai
Yu, Xiu‐chun
Xu, Ming
Yang, Yang
author_sort Zheng, Kai
collection PubMed
description OBJECTIVES: To evaluate treatments and prognostic factors for the myxoid liposarcoma in extremities. METHODS: We retrospectively reviewed 34 patients histologically diagnosed with myxoid liposarcoma arising in the extremities, treated in our hospital from 2010 to 2017. We recorded tumor locations, max diameter, operations, complications, radiation, chemotherapy, survival, recrudescence, and metastases. Overall survival, treatments, and prognostic factors were subsequently analyzed. RESULTS: The mean age of 34 patients with myxoid liposarcoma in extremities was 49.1 years, and the mean follow‐up period was 65.1 months. The median survival time was 190 months. Five of 14 patients accepted recrudescence resection and two patients of 20 patients who underwent primary tumor resection or unplanned operation died of tumor progression. Although no statistical difference was found (X (2) = 3.331, P = 0.068), the lower mortality was confirmed in the patients who accepted primary tumor resection or unplanned operation. Eleven patients with a tumor diameter of 8.6 ± 4.7 cm accepted wide resection, while 23 patients with 17.2 ± 8.8 cm tumors accepted marginal resection. Statistical difference was found between the size of tumors with relatively wide resection and those with relatively marginal resection (F = 9.130, P = 0.005). No recurrence or metastasis occurred in patients who accepted wide resection, while 14 patients presented with local recurrence and 8 patients developed distant metastases among the 23 patients with marginal resection. Seven patients died of metastases, while one patient lived with metastases. No significant difference in survival was found between different surgical methods (X (2) = 0.9460, P = 0.3307). The average diameter of eight patients with distant metastases was 21.7 cm, which was considerable larger than the 12.1 cm of patients without metastasis. This difference was proven significant upon the statistical analysis (F = 9.412, P = 0.004). CONCLUSIONS: Wide resection achieved good local control but was not unambiguously superior in long‐term survival. Myxoid liposarcoma tumors with larger diameters were more difficult to be submitted to wide resection and were more likely to present with distant metastasis.
format Online
Article
Text
id pubmed-6904597
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-69045972019-12-20 Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study Zheng, Kai Yu, Xiu‐chun Xu, Ming Yang, Yang Orthop Surg Clinical Articles OBJECTIVES: To evaluate treatments and prognostic factors for the myxoid liposarcoma in extremities. METHODS: We retrospectively reviewed 34 patients histologically diagnosed with myxoid liposarcoma arising in the extremities, treated in our hospital from 2010 to 2017. We recorded tumor locations, max diameter, operations, complications, radiation, chemotherapy, survival, recrudescence, and metastases. Overall survival, treatments, and prognostic factors were subsequently analyzed. RESULTS: The mean age of 34 patients with myxoid liposarcoma in extremities was 49.1 years, and the mean follow‐up period was 65.1 months. The median survival time was 190 months. Five of 14 patients accepted recrudescence resection and two patients of 20 patients who underwent primary tumor resection or unplanned operation died of tumor progression. Although no statistical difference was found (X (2) = 3.331, P = 0.068), the lower mortality was confirmed in the patients who accepted primary tumor resection or unplanned operation. Eleven patients with a tumor diameter of 8.6 ± 4.7 cm accepted wide resection, while 23 patients with 17.2 ± 8.8 cm tumors accepted marginal resection. Statistical difference was found between the size of tumors with relatively wide resection and those with relatively marginal resection (F = 9.130, P = 0.005). No recurrence or metastasis occurred in patients who accepted wide resection, while 14 patients presented with local recurrence and 8 patients developed distant metastases among the 23 patients with marginal resection. Seven patients died of metastases, while one patient lived with metastases. No significant difference in survival was found between different surgical methods (X (2) = 0.9460, P = 0.3307). The average diameter of eight patients with distant metastases was 21.7 cm, which was considerable larger than the 12.1 cm of patients without metastasis. This difference was proven significant upon the statistical analysis (F = 9.412, P = 0.004). CONCLUSIONS: Wide resection achieved good local control but was not unambiguously superior in long‐term survival. Myxoid liposarcoma tumors with larger diameters were more difficult to be submitted to wide resection and were more likely to present with distant metastasis. John Wiley & Sons Australia, Ltd 2019-11-12 /pmc/articles/PMC6904597/ /pubmed/31721459 http://dx.doi.org/10.1111/os.12566 Text en © 2019 The Authors. Orthopaedic Surgery published by Chinese Orthopaedic Association and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Articles
Zheng, Kai
Yu, Xiu‐chun
Xu, Ming
Yang, Yang
Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study
title Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study
title_full Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study
title_fullStr Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study
title_full_unstemmed Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study
title_short Surgical Outcomes and Prognostic Factors of Myxoid Liposarcoma in Extremities: A Retrospective Study
title_sort surgical outcomes and prognostic factors of myxoid liposarcoma in extremities: a retrospective study
topic Clinical Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904597/
https://www.ncbi.nlm.nih.gov/pubmed/31721459
http://dx.doi.org/10.1111/os.12566
work_keys_str_mv AT zhengkai surgicaloutcomesandprognosticfactorsofmyxoidliposarcomainextremitiesaretrospectivestudy
AT yuxiuchun surgicaloutcomesandprognosticfactorsofmyxoidliposarcomainextremitiesaretrospectivestudy
AT xuming surgicaloutcomesandprognosticfactorsofmyxoidliposarcomainextremitiesaretrospectivestudy
AT yangyang surgicaloutcomesandprognosticfactorsofmyxoidliposarcomainextremitiesaretrospectivestudy